参考文献/References:
[1] Mechanick JI,Zhao S,Garvey WT. Leptin,an adipokine with central importance in the global obesity problem[J]. Glob Heart,2018,13(2):113-127.
[2] Jiang B,Liu Y,Liu Y,et al. Association of four insulin resistance genes with type 2 diabetes mellitus and hypertension in the Chinese Han population[J]. Mol Biol Rep,2014,41(2):925-933.
[3] Schaab M,Kratzsch J. The soluble leptin receptor[J]. Best Pract Res Clin Endocrinol Metab,2015,29(5):661-670.
[4] Sun Q,Cornelis MC,Kraft P,et al. Genome-wide association study identifies polymorphisms in LEPR as determinants of plasma soluble leptin receptor levels[J]. Hum Mol Genet,2010,19(9):1846-1855.
[5] Puurunen VP,Kiviniemi A,Lepoj?rvi S,et al. Leptin predicts short-term major adverse cardiac events in patients with coronary artery disease[J]. Ann Med,2017,49(5):448-454.
[6] Tsai JP,Wang JH,Chen ML,et al. Association of serum leptin levels with central arterial stiffness in coronary artery disease patients[J]. BMC Cardiovasc Disord,2016,16:80.
[7] Katsiki N,Mikhailidis DP,Banach M. Leptin,cardiovascular diseases and type 2 diabetes mellitus[J]. Acta Pharmacol Sin,2018,39(7):1176-1188.
[8] Yang R,Barouch LA. Leptin signaling and obesity:cardiovascular consequences[J]. Circ Res,2007,101(6):545-559.
[9] Drosos I,Chalikias G,Pavlaki M,et al. Differences between perivascular adipose tissue surrounding the heart and the internal mammary artery:possible role for the leptin-inflammation-fibrosis-hypoxia axis[J]. Clin Res Cardiol,2016,105(11):887-900.
[10] Bodary PF,Shen Y,Ohman M,et al. Leptin regulates neointima formation after arterial injury through mechanisms independent of blood pressure and the leptin receptor/STAT3 signaling pathways involved in energy balance[J]. Arterioscler Thromb Vasc Biol,2007,27(1):70-76.
[11] Recio-Mayoral A,Rimoldi OE,Camici PG,et al. Inflammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease[J]. JACC Cardiovasc Imaging,2013,6(6):660-667.
[12] Akboga MK,Canpolat U,Balci KG,et al.Increased platelet to lymphocyte ratio is related to slow coronary flow[J]. Angiology,2016,67(1):21-26.
[13] de Rosa S,Cirillo P,Pacileo M,et al. Leptin stimulated C-reactive protein production by human coronary artery endothelial cells[J]. J Vasc Res,2009,46(6):609-617.
[14] Gamez-Mendez AM,Vargas-Robles H,Ríos A,et al. Oxidative stress-dependent coronary endothelial dysfunction in obese mice[J]. PLoS One,2015,10(9):e0138609.
[15] Allison MA,Jenny NS,McClelland RL,et al. The associations of adipokines with selected markers of the renin-angiotensinogen-aldosterone system:the multi-ethnic study of atherosclerosis[J]. J Hum Hypertens,2015,29(2):127-133.
[16] Bakirdogen S,Eren N,Bek SG,et al. The effects of serum leptin levels on thrombocyte aggregation in peritoneal dialysis patients[J]. Pak J Med Sci,2016,32(6):1464-1467.
[17] Vilahur G,Ben-Aicha S,Badimon L. New insights into the role of adipose tissue in thrombosis[J]. Cardiovasc Res,2017,113(9):1046-1054.
[18] Mansor LS,Mehta K,Aksentijevic D,et al. Increased oxidative metabolism following hypoxia in the type 2 diabetic heart,despite normal hypoxia signalling and metabolic adaptation[J]. J Physiol,2016,594(2):307-320.
[19] Matsuoka N,Ogawa Y,Hosoda1 K,et al. Human leptin receptor gene in obese Japanese subjects:evidence against either obesity-causing mutations or association of sequence variants with obesity[J]. Diabetologia,1997,40(10):1204-1210.
[20] Nowzari Z,Masoumi M,Nazari-Robati M,et al. Association of polymorphisms of leptin,leptin receptor and apelin receptor genes with susceptibility to coronary artery disease and hypertension[J]. Life Sci,2018,207:166-171.
[21] Kain D,Simon AJ,Greenberg A,et al. Cardiac leptin overexpression in the context of acute MI and reperfusion potentiates myocardial remodeling and left ventricular dysfunction[J]. PLoS One,2018,13(10):e0203902.
[22] Boumaiza I,Omezzine A,Rejeb J,et al. Relationship between leptin G2548A and leptin receptor Q223R gene polymorphisms and obesity and metabolic syndrome risk in Tunisian volunteers[J]. Genet Test Mol Biomarkers,2012,16(7):726-733.
[23] Lian Y,Tang Z,Xie Y,et al Leptin receptor gene polymorphisms and risk of hypertension:a meta-analysis[J]. Int J Clin Exp Med,2015,8(8):14277-14282.
[24] Sun YM,Wang LF,Li J,et al. The 223A>G polymorphism of the leptin receptor gene and lipid-lowering efficacy of simvastatin in Chinese patients with coronary heart disease[J]. Eur J Clin Pharmacol,2009,65(2):157-161.
[25] Khaki-Khatibi F,Mansouri F,Hajahmadipoorrafsanjani M,et al. Study of rs1137101 polymorphism of leptin receptor gene with serum levels of selenium and copper in the patients of non-ST-segment elevation myocardial infarction (NSTEMI) in an Iranian population[J]. Clin Biochem,2018,60:64-70.
[26] Li XL,Sui JQ,Lu LL,et al. Gene polymorphisms associated with non-alcoholic fatty liver disease and coronary artery disease:a concise review[J]. Lipids Health Dis,2016,15:53.
[27] Okada T,Ohzeki T,Nakagawa Y,et al. Impact of leptin and leptin-receptor gene polymorphisms on serum lipids in Japanese obese children[J]. Acta Paediatr ,2010,99(8):1213-1217.
[28] Furusawa T,Naka I,Yamauchi T,et al. The Q223R polymorphism in LEPR is associated with obesity in pacific islanders[J]. Hum Genet,2010,127(3):287-294.
[29] Yang MM,Wang J,Fan JJ,et al. Variations in the obesity gene "LEPR" contribute to risk of type 2 diabetes mellitus:evidence from a meta-analysis[J]. J Diabetes Res,2016,2016:5412084.
[30] Saukko M,Kes?niemi YA,Ukkola O. Leptin receptor Lys109Arg and Gln223Arg polymorphisms are associated with early atherosclerosis[J]. Metab Syndr Relat Disord,2010,8(5):425-430.
[31] Wu L,Sun D. Leptin receptor gene polymorphism and the risk of cardiovascular disease:a systemic review and meta-analysis[J]. Int J Environ Res Public Health,2017,14(4).
[32] ?ij?l? M,Santaniemi M,Bloigu R,et al. Leptin receptor Arg109 homozygotes display decreased total mortality as well as lower incidence of cardiovascular disease and related death[J]. Gene,2014,534(1):88-92.
[33] Wauman J,Tavernier J. Leptin receptor signaling:pathways to leptin resistance[J]. Front Biosci (Landmark Ed),2011,16:2771-2793.
[34] Elliott P,Chambers JC,Zhang W,et al. Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease[J]. JAMA,2009,302(1):37-48.
[35] Xiao P,Shi J,Liu X. Associations of leptin and leptin receptor genetic variants with coronary artery disease:a meta-analysis[J]. Biosci Rep,2019,39(6).pii: BSR20190466.
相似文献/References:
[1]赵丹 周鹏.达比加群及其逆转剂在心血管疾病中的研究进展[J].心血管病学进展,2019,(5):801.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.034]
ZHAO DanZHOU Peng.Dabigatran and Reversal in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(8):801.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.034]
[2]石文坚 花蕾 孟祥光 袁义强.环状RNA在冠状动脉粥样硬化性心脏病中的研究进展[J].心血管病学进展,2019,(9):1286.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.026]
SHI Wenjian,HUA Lei,MENG Xiangguang,et al.CircRNA in Coronary Atherosclerotic Heart Disease[J].Advances in Cardiovascular Diseases,2019,(8):1286.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.026]
[3]孙涛 左权 周辉 刘安康 梁诚 汤圣兴.末梢桡动脉和无鞘技术在冠状动脉介入治疗中的应用现状[J].心血管病学进展,2020,(5):456.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.005]
[4]奚云萍 臧雁翔 李为民.临床SYNTAX计分及其衍生计分在冠心病血运重建预后中的应用价值[J].心血管病学进展,2020,(5):452.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.004]
XI Yunping,ZANG Yanxiang,LI Weimin.Value of Clinical SYNTAX Score and Its Derivative Score in Prognosis of Coronary Artery Disease with Revascularization[J].Advances in Cardiovascular Diseases,2020,(8):452.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.004]
[5]肖亚楠 高传玉 朱中玉.低剂量替格瑞洛在冠心病中的应用前景[J].心血管病学进展,2020,(7):706.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.009]
XIAO Yanan,GAO Chuanyu,ZHU Zhongyu.Application Prospects of Low-dose Ticagrelor in Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2020,(8):706.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.009]
[6]史云聪,王立立 郭艺芳.维生素D与心血管疾病相关性研究进展[J].心血管病学进展,2020,(8):826.[doi:10.16806/j.cnki.issn.1004-3934.20.08.011]
SHI YuncongWANG LiliGUO Yifang.Vitamin D And Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(8):826.[doi:10.16806/j.cnki.issn.1004-3934.20.08.011]
[7]李英 刘兴鹏.常见心血管病服药依从性[J].心血管病学进展,2020,(10):1016.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.000]
LI Ying,LIU Xingpeng.Medication Adherence For Common Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2020,(8):1016.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.000]
[8]肖亚楠 高传玉.经皮冠脉介入术后短程双联抗血小板治疗的研究进展[J].心血管病学进展,2021,(4):318.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.008]
XIAO Yanan,GAO Chuanyu.Short-term Dual Antiplatelet Therapy after Percutaneous Coronary Intervention[J].Advances in Cardiovascular Diseases,2021,(8):318.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.008]
[9]吉蓉 寿锡凌.秋水仙碱在冠状动脉粥样硬化性心脏病防治中的研究进展与争议[J].心血管病学进展,2022,(1):60.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.016]
JI Rong,SHOU Xiling.Research Progress and Controversy of Colchicine in Prevention and Treatment of Coronary Atherosclerotic Heart Disease[J].Advances in Cardiovascular Diseases,2022,(8):60.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.016]
[10]赵攀果 黄毅雄 肖丽苹 李田昌.基于声学理论检测冠心病的新方法[J].心血管病学进展,2022,(12):1068.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.003]
ZHAO PanguoHUANG YixiongXIAO LipingLI Tianchang.A New Method for the Diagnosis of Coronary Artery Disease Based on Acoustic Theory[J].Advances in Cardiovascular Diseases,2022,(8):1068.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.003]